Reference
FDA. Statement from FDA Commissioner Scott Gottlieb, M.D., on new policy to improve access and foster price competition for drugs that face inadequate generic competition. Internet Document : 15 Feb 2019. Available from: URL: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm631456.htm
Rights and permissions
About this article
Cite this article
FDA issues draft guidance on Competitive Generic Therapies. PharmacoEcon Outcomes News 822, 35 (2019). https://doi.org/10.1007/s40274-019-5687-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5687-y